The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Tuesday, October 26, 2021
The FDA issued a draft guidance for industry titled Data Standards for Drug and Biological Product Submissions Containing Real-World Data. The ...
read more
Wednesday, October 13, 2021
Aceto, a leading global provider of specialty materials for life sciences and advanced technology end markets, announced its acquisition of A&C Bio ...
read more
Wednesday, October 13, 2021
Pacira BioSciences, the industry leader in its commitment to non-opioid pain management and regenerative health solutions, and Flexion Therapeutics, ...
read more
Wednesday, October 13, 2021
Agenus Inc, an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to ...
read more
Wednesday, October 13, 2021
Immusoft, a cell therapy company dedicated to improving the lives of patients with rare diseases, announced that it has signed a research ...
read more
Curative Biotechnology announced as agreement with Mid-Atlantic BioTherapeutics (MABT) to broaden the license for IMT504, a novel patented ...
read more
Thursday, October 07, 2021
EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, and ...
read more
Thursday, October 07, 2021
Luciole Pharmaceuticals, a startup company focused on the discovery and development of small molecules that enhance the repair of oxidative damage to ...
read more
Wednesday, October 06, 2021
Xencor a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune...
read more
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $3M in funding for 6 new ...
read more
Thursday, September 30, 2021
Merck, a publicly traded biopharmaceutical company, announced that the companies have entered into a definitive agreement under which Merck, through a...
read more
Thursday, September 30, 2021
The CDC Foundation is announcing the launch of its new Vaccine Resource Hub—an online platform that will provide access to hundreds of free and ...
read more
Wednesday, September 29, 2021
AstraZeneca’s Alexion has exercised its option to acquire all remaining equity in Caelum Biosciences for CAEL-101, a potentially first-in-class fibril...
read more
Thursday, September 23, 2021
SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-...
read more
Thursday, September 23, 2021
AstraZeneca has reached an agreement to collaborate with VaxEquity for the discovery, development and commercialization of the proprietary self-...
read more